Calcium channel blockers and asthma.
S Y
SY
So
M
M
Ip
W K
WK
Lam
D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001980:Bronchi / Q000187:drug effects / Q000503:physiopathology; D001993:Bronchodilator Agents; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D002448:Cell Adhesion; D002936:Cinnarizine / Q000627:therapeutic use; D004285:Dogs; D006168:Guinea Pigs; D006636:Histamine Release; D006801:Humans; D007473:Ion Channels / Q000502:physiology; D008407:Mast Cells / Q000378:metabolism; D009130:Muscle, Smooth / Q000503:physiopathology; D009543:Nifedipine / Q000627:therapeutic use; D005082:Physical Exertion; D012756:Sheep; D014700:Verapamil / Q000627:therapeutic use
D001993:Bronchodilator Agents; D002121:Calcium Channel Blockers; D007473:Ion Channels; D002936:Cinnarizine; D014700:Verapamil; D009543:Nifedipine; D002118:Calcium